Clostridium difficile: still costly, still difficult to treat, and still here

Trafford, G. Journal of Hospital Infection | Published online: 18 March 2017
Image source: David Goulding, Wellcome Trust Sanger Institute – Wellcome Images // CC BY-NC-ND 4.0

Clostridium difficile infection (CDI) remains a formidable problem in the healthcare setting and there is much left to learn regarding the biology of this troublesome pathogen. This special section in this issue of the Journal contains a range of papers covering the epidemiology, treatment, and costs of CDI. Individual cases and outbreaks come at considerable cost to institutions, with the subset of patients who fail to respond to conventional antibiotic therapy presenting an even greater morbidity risk and cost largely due to increased length of stay

Read the abstract here


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.